What is driving ALNEV.PA stock volume today?

Pre-market flows and low free float are driving volume in ALNEV.PA stock today. Small trades can generate large percentage moves in this microcap, and sector chatter or algorithmic screens often amplify activity.

How risky is investing in ALNEV.PA stock?

ALNEV.PA stock is high risk due to negative EPS, thin liquidity, and limited recent earnings updates. Positions can swing widely intraday, so risk controls and small sizing are essential.

What financial ratios should I watch for ALNEV.PA stock?

Focus on current ratio (**0.63**), cash per share (**2.50**), and EPS (**-221.36**). These metrics signal short-term liquidity constraints and negative profitability for ALNEV.PA stock.

Does Meyka AI provide a forecast for ALNEV.PA stock?

Yes. Meyka AI's forecast model projects a 12-month reference of **€0.005** for ALNEV.PA stock, implying **150.00%** upside versus the current **€0.002**. Forecasts are projections, not guarantees.

EU Stocks

Pre-Market Most Active: ALNEV.PA stock €0.002 on 12 Feb 2026: Watch volume surge

ByHuzaifa Zahoor February 12, 2026February 12, 2026

ALNEV.PA stock is trading at €0.002 in pre-market on EURONEXT on 12 Feb 2026 with 11,130,794.00 shares changing hands, making Neovacs S.A. one of the most active tickers this session. The move comes despite a long pause in reported earnings and a tiny market cap of €906.00, signalling speculative flows rather than fresh fundamentals. We flag the spike for traders watching liquidity and volatility in the Healthcare / Biotechnology group and outline key ratios, technicals, and a short-term model forecast.